![](/img/cover-not-exists.png)
Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors
Romero Prada, ME, Gomez de la rosa, F, Alvis-Zakzuk, NJ, Carrasquilla-Sotomayor, M, Alvis-Zakzuk, JS, Zakzuk-Sierra, JVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.500
Date:
November, 2016
File:
PDF, 65 KB
english, 2016